Clinical trial
A Phase 2a, Multi-centre, Placebo Controlled, Randomized, Assessor Blind Study of Bolus 5-fluorouracil and Infused Leucovorin Plus Either Infused TK-90 for Parenteral Use or Infused TK-90 Placebo Administered Weekly for 6 Consecutive Weeks to Patients With Colorectal Cancer.
NCT05669521 is registered in ClinicalTrials.gov with Tosk, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2a, Multi-centre, Placebo Controlled, Randomized, Assessor Blind Study of Bolus 5-fluorouracil and Infused Leucovorin Plus Either Infused TK-90 for Parenteral Use or Infused TK-90 Placebo Administered Weekly for 6 Consecutive Weeks to Patients With Colorectal Cancer.
- Lead sponsor
- Tosk, Inc.
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- June 15, 2022
- Completion date
- September 30, 2023
- Enrollment
- 24 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.